KRAS mutations are commonly missense mutations, the majority of which are in codon 12 of the gene [3–6], quite common in colorectal cancer (CRC) and non-small cell lung cancer (NSCLC), where they have been associated with poor prognosis [4, 5, 7–9]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.